Anti-retroviral Drugs Market Share

Statistics for the 2023 & 2024 Anti-retroviral Drugs market share, created by Mordor Intelligence™ Industry Reports. Anti-retroviral Drugs share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Anti-retroviral Drugs Industry

The anti-retroviral market is fragmented due to many companies operating globally and regionally. The competitive landscape includes an analysis of a few international, as well as local companies which hold the market shares and are well-known, are AbbVie Inc., Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd, Gilead Sciences, Inc., Merck & Co, Inc., Viatris Inc. (Mylan Inc.), GlaxoSmithKline plc (ViiV Healthcare), Cipla Inc., Johnson and Johnson, Pfizer Inc. and Teva Pharmaceutical Industries Ltd.

Anti-Retroviral Drugs Market Leaders

  1. Boehringer Ingelheim International GmbH

  2. Bristol-Myers Squibb Company

  3. Gilead Sciences, Inc.

  4. Merck & Co, Inc.

  5. GlaxoSmithKline plc (ViiV Healthcare)

*Disclaimer: Major Players sorted in no particular order

Anti-retroviral Drugs Market  Concentration

Anti-retroviral Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)